About Prapela
Prapela is a Medical Device company, headquartered in Biddeford, with 11 - 50 employees and annual revenue of $1M - $5M.
Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received o...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Prapela Company Highlights
Phone Number
(833) 772-xxxx
Corporate Office Address
2 Main Street
Biddeford, 04005
Website
Prapela Org
Prapela has 1 C-Level, 1 VP, and 2 Other employees.
Prapela Decision Makers
- CEOJohn Konsin
Prapela's Tech Stack
Frequently Asked Questions About
Prapela
Log in or sign up to get full contact details and additional support.
Who is the CEO of Prapela?
The CEO of Prapela is John Konsin. See full contact details ›
How many senior employees does Prapela have?
Prapela has 2 senior employees that are typically used for decision making.
Who are the key decision makers at Prapela?
Key decision makers at Prapela include John Konsin (CEO). See full contact details ›
What technologies does Prapela use?
Prapela uses technologies including G Suite, Google Cloud, and Handlebars.
How do I contact Prapela?
To contact Prapela, visit prapela.com.
What companies are similar to Prapela?
Companies similar to Prapela include MST, TTG Imaging Solutions, and NovaSignal.
Where is Prapela headquartered?
Prapela is headquartered at 2 Main Street, Biddeford.
What is the main phone number for Prapela?
The main phone number for Prapela is (833) 772-xxxx.
What is the official website for Prapela?
The official website for Prapela is prapela.com.
What is the annual revenue of Prapela?
The annual revenue of Prapela is $1M - $5M.
How many employees does Prapela have?
Prapela has 11 - 50 employees.
What industry is Prapela in?
Prapela is in the Medical Device industry.
Last updated: October 10, 2024